Concord Drugs Limited Share Price

Concord Drugs Limited is an India-based pharmaceutical company. The Company's principal activity is to manufacture licensed drugs based on the formulations approved. The Company is focused on developing drug delivery systems, including multiple unit pellet system (MUPS), sustained release, and modified release pellets. It operates a Current Good Manufacturing Practice (cGMP) contract manufacturing formulation-fill-finish facility, offering a full spectrum of pharmaceutical development and manufacturing services for drug products. The Company's products include pharmaceutical ready to fill pellets, MUPS; tissue bio adhesive; injectables (small volume parenterals); oral solid dosages (tablets); oral solid dosages (capsules); liquid orals, and dry syrup (powder). It also offers hand sanitizers under the brand name, PROTON SAFE. It manufactures hand sanitizers on third party basis also. The Company's oral liquid dosage forms include solutions, syrups, and suspensions.As of 25 May 2026, Concord Drugs Limited share price is ₹79.20. The stock opened at ₹77.00, compared to its previous close of ₹77.74. During today's trading session, Concord Drugs Limited share price moved in the range of ₹77.00 to ₹83.50, with an average price of ₹80.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹77.00 and a high of ₹83.50.

The market capitalization of Concord Drugs Limited is ₹102 Crs, with a P/E ratio of 180.8 and a dividend yield of 0.00%.